NAD+, Stress & Mood: What's the Real Link?

Chronic stress and low mood drain mental clarity as much as anything on this site — the heavy, slowed, can't-focus feeling that people often call "brain fog" is frequently the cognitive face of an untreated mood or stress problem. So it's no surprise that NAD+ products are increasingly marketed as a way to lift mood, blunt stress, and "rebalance" the stressed brain. The biology connecting NAD+ to stress and mood is genuinely interesting. But the honest headline is the one that runs through everything here: an interesting biological link is not the same as a supplement that has been shown to make people feel better. As of now, no randomized trial demonstrates that an NAD+ precursor improves mood or treats depression in humans. This page walks through what the link actually is, what it isn't, and what does move mood.

Why people connect NAD+ to stress and mood

The pitch isn't invented from nothing. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme at the center of cellular energy metabolism and a substrate for repair and signalling enzymes, including the sirtuins (notably SIRT1). Sirtuins sit on several pathways relevant to the brain's stress response and to mood regulation, which is why NAD+ keeps surfacing in depression research. Reviews of this biology describe how SIRT1 signalling intersects with the molecular pathways implicated in depression³, and preclinical work has explored boosting NAD+-dependent SIRT1 activity — for example with dietary polyphenols — as a strategy against stress-induced depressive behaviour in animal models².

There is even a thread of human mechanistic data. A 2026 study reported preliminary evidence that blood levels of extracellular NAMPT — the rate-limiting enzyme that makes NAD+ — increase as patients respond to antidepressant treatment, whether the treatment was chronotherapeutics or monoaminergic drugs¹. That's a real, intriguing finding: it ties the NAD+-synthesis machinery to the process of getting better. But read it precisely. It shows NAD+ metabolism moving alongside recovery driven by established treatments — it does not show that pushing NAD+ up with a supplement causes recovery. Correlation in the direction of the marketing is not the same as the supplement working.

The leap the marketing makes

Here's the gap. Mechanism and biomarker associations tell you a hypothesis is plausible — that NAD+ metabolism is entangled with mood in ways worth studying. Only a trial that gives people an NAD+ precursor and measures their mood against placebo can tell you whether topping up NAD+ does anything you can feel. That second kind of evidence is what's missing.

This matters because the same molecule has already been tested for the cognitive side of this story and come up short. In the best randomized, placebo-controlled trials, NAD+ precursors reliably raise blood NAD+ several-fold and still do not beat placebo for the outcomes people care about. A 2025 trial of nicotinamide riboside in long-COVID — a population defined partly by low mood, fatigue, and fog — raised NAD+ about 3-fold but found no significant differences versus placebo in cognition, fatigue, sleep, or mood⁴. A separate randomized trial of NR in older adults with mild cognitive impairment again raised NAD+ with no cognitive benefit over placebo⁵. We unpack the energy-and-fatigue version of this in NAD+ for Cognitive Energy & Fatigue, and the precursor-by-precursor brain data in NMN & NR for Brain Health. The pattern is consistent: the marker moves, the experience doesn't.

A systematic review of NAD across clinical conditions lands in the same sober place — these interventions are generally well tolerated, but the evidence for benefit is inconsistent and the strongest claims outrun the data⁶. There is, as of this writing, no published randomized controlled trial showing that an NAD+ precursor relieves depression or anxiety or measurably improves mood in humans. That absence is the single most important fact on this page.

A precursor caveat worth flagging

It's also worth separating NAD+ precursors from old-fashioned vitamin B3. Niacin and nicotinamide are NAD+ precursors and are essential nutrients — severe deficiency (pellagra) genuinely causes mood and cognitive symptoms that correcting the deficiency reverses. But that's a deficiency-correction story, not evidence that extra NAD+ on top of an adequate diet lifts mood. The modern products in question are NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide), sold as supplements, not approved drugs — and supplement, not drug, is the correct mental category here. Neither carries a mood indication, and neither has the trial evidence to support one⁷.

Mood and stress are multifactorial — rule in real causes first

The reason the NAD+ pitch is so seductive is that low mood and chronic stress feel like a single problem with, surely, a single fix. They aren't. Persistent low mood, irritability, and the foggy thinking that comes with them are non-specific and sit on top of treatable drivers worth ruling in before any supplement:

• •Sleep. Poor and insufficient sleep degrades mood and the attention and processing speed that make you feel clear-headed; it's the strongest, best-evidenced lever⁸. Chronic short sleep also worsens stress reactivity.
• •Thyroid. Both overt and subtler thyroid dysfunction independently affect mood and cognition in adults, and hypothyroidism is a classic, easily-missed cause of low, sluggish mood that a simple blood test catches and treatment reverses⁹.
• •Vitamin B12. Deficiency is a recognised, reversible cause of low mood, fatigue, and cognitive slowing — and it's routinely missed¹⁰.
• •An actual mood condition. Depression and anxiety are common, treatable, and not a supplement problem. If low mood is persistent or affecting your life, the highest-yield step is a clinician, not a bottle. When anxiety itself is the driver, the foggy thinking is downstream of it — we unpack that mechanism in Anxiety Brain Fog: Why Worry Clouds Your Thinking — and when depression is the driver, the fog is similarly downstream and near-universal, covered in Depression and Brain Fog.

We map the full set of drivers in What Actually Causes Brain Fog?, and the post-viral version — where "rebalance your brain chemistry" claims are loudest — in NAD+ for Long-COVID Brain Fog. Substance withdrawal carries its own low-mood-plus-fog stretch: the recovery arc after stopping cannabis is covered in brain fog after quitting weed. And because stress-driven exhaustion is where adaptogens are pitched hardest, we hold them to the same evidence bar in Rhodiola rosea for brain fog and mental fatigue — promising for stress-related fatigue, but built on contradictory, flawed trials.

What actually moves mood

If you want evidence-backed levers for mood and stress, they exist — and they aren't on the NAD+ shelf:

• •Exercise. A 2024 systematic review and network meta-analysis in The BMJ found that exercise — especially walking or jogging, strength training, and yoga — produced moderate reductions in depressive symptoms, with effects comparable to or complementing psychotherapy and medication¹¹. This is among the strongest non-drug signals in the literature.
• •Treat the underlying condition. For diagnosable depression or anxiety, evidence-based psychotherapy and/or medication remain the proven path; NAMPT/NAD+ markers appear to follow that recovery, not lead it¹.
• •Set honest expectations for supplements. Even popular nutrient fixes underwhelm: a meta-analysis of vitamin D for primary depression found supplementation did not reliably reduce depressive symptoms¹². NAD+ precursors raise the biomarker and have a clean safety record⁶, but have no mood trial behind them at all — which puts them below even the modest nutrient interventions, not above them.

The bottom line

NAD+, stress, and mood are linked — but the link is biological and associative, not therapeutic. Sirtuin and NAD+ pathways are entangled with the brain's stress response, and in humans the NAD+-making enzyme NAMPT appears to rise as people recover on established antidepressants. That's a reason to keep studying NAD+ metabolism, not a reason to take NR or NMN for your mood. No randomized trial shows an NAD+ precursor improves mood or treats depression, and the closely related cognitive and fatigue trials have come back null against placebo. If stress and low mood are weighing on you, the proven moves are unglamorous and effective: protect sleep, rule in thyroid and B12, get exercise, and treat an actual mood condition with care that has evidence behind it. For the full picture on the molecule, see our pillar, Does NAD+ Help Brain Fog? An Evidence Check; and if you still want to weigh cognitive-energy and mood products against this evidence bar rather than the marketing, our best cognitive-energy picks rank providers honestly.